274 related articles for article (PubMed ID: 3418520)
21. Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure.
Anderson DR; Harris LW; Lennox WJ; Solana RP
Drug Chem Toxicol; 1991; 14(1-2):1-19. PubMed ID: 1889370
[TBL] [Abstract][Full Text] [Related]
22. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo.
Xia DY; Wang LX; Pei SQ
Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786
[TBL] [Abstract][Full Text] [Related]
23. A comparison of physostigmine and soman using taste aversion and nociception.
Romano JA; King JM; Penetar DM
Neurobehav Toxicol Teratol; 1985; 7(3):243-9. PubMed ID: 4033865
[TBL] [Abstract][Full Text] [Related]
24. Effects of inhibitors of acetylcholine synthesis on brain acetylcholine and survival in soman-intoxicated animals.
Harris LW; Stitcher DL; Hey WC
Life Sci; 1982 May; 30(22):1867-73. PubMed ID: 7109825
[TBL] [Abstract][Full Text] [Related]
25. Protection of guinea pigs against soman poisoning with ferrocene carbamate.
Karlsson N; Larsson R; Puu G
Arch Toxicol; 1992; 66(9):629-32. PubMed ID: 1482285
[TBL] [Abstract][Full Text] [Related]
26. Detoxification of soman and o-cyclopentyl-s-diethylaminoethyl methylphosphonothioate in vivo.
Harris L; Broomfield C; Adams N; Stitcher D
Proc West Pharmacol Soc; 1984; 27():315-8. PubMed ID: 6494170
[No Abstract] [Full Text] [Related]
27. Acute behavioral toxicity of pyridostigmine or soman in primates.
Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
[TBL] [Abstract][Full Text] [Related]
28. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
[TBL] [Abstract][Full Text] [Related]
29. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
[TBL] [Abstract][Full Text] [Related]
30. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
Shiloff JD; Clement JG
Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
[TBL] [Abstract][Full Text] [Related]
31. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
32. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
Wetherell JR
J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
[TBL] [Abstract][Full Text] [Related]
33. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
Maxwell DM; Brecht KM; Koplovitz I; Sweeney RE
Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629
[TBL] [Abstract][Full Text] [Related]
34. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds.
Maxwell DM
Toxicol Appl Pharmacol; 1992 Jun; 114(2):306-12. PubMed ID: 1609424
[TBL] [Abstract][Full Text] [Related]
35. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
36. Carbamoylated enzyme reversal as a means of predicting pyridostigmine protection against soman.
Ellin RI; Kaminskis A
J Pharm Pharmacol; 1989 Sep; 41(9):633-6. PubMed ID: 2573709
[TBL] [Abstract][Full Text] [Related]
37. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning.
Carpentier P; Foquin-Tarricone A; Bodjarian N; Rondouin G; Lerner-Natoli M; Kamenka JM; Blanchet G; Denoyer M; Lallement G
Neurotoxicology; 1994; 15(4):837-51. PubMed ID: 7715855
[TBL] [Abstract][Full Text] [Related]
38. Pyridostigmine-induced decrement in skeletal muscle contracture is not augmented by soman.
Anderson RJ; Chamberlain WL
Neurotoxicology; 1988; 9(1):89-96. PubMed ID: 3393305
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.
Lucić Vrdoljak A; Radić B; Garaj-Vrhovac V; Kopjar N; Zlender V
J Appl Toxicol; 2006; 26(1):56-63. PubMed ID: 16167315
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
